2020 annual financial data

Capricor Therapeutics, Inc. 2020 Operating margin

Capricor Therapeutics, Inc. 2020 operating margin with verified reported values.

Direct answer

Operating margin was -4,412.56%.

Operating income was -13,689,971 USD and net income was -13,657,028 USD.
Operating cash flow was -10,054,810 USD.

Get free Capricor Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
310,250 USD
Operating income
-13,689,971 USD
Net income
-13,657,028 USD
Operating cash flow
-10,054,810 USD